Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Opsoclonus-Myoclonus Syndrome × Cyclophosphamide × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 101 Lymphoma, Large B-Cell, Diffuse 80 Leukemia, Myeloid, Acute 73 Multiple Myeloma 65 Breast Neoplasms 60 Lymphoma, Non-Hodgkin 58 Lymphoma 58 Leukemia, Lymphocytic, Chronic, B-Cell 51 Burkitt Lymphoma 49 Myelodysplastic Syndromes 47 Lymphoma, Follicular 47 Lymphoma, B-Cell 46 Leukemia 39 Recurrence 38 Lymphoma, Mantle-Cell 38 Neoplasms 33 Hematologic Neoplasms 33 Triple Negative Breast Neoplasms 32 Lymphoma, B-Cell, Marginal Zone 31 Hodgkin Disease 31 Melanoma 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 21 Ovarian Neoplasms 21 Neuroblastoma 21 Pancreatic Neoplasms 20 Leukemia, Biphenotypic, Acute 18 Neoplasm Metastasis 17 Leukemia, Myelomonocytic, Chronic 17 Myeloproliferative Disorders 15

Interventions

thymoglobulin 1 prednylidene 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Etoposide 1 Cytarabine 1 Carmustine 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡